A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W

Chr. Hansen

Company-logo  COMPANY DETAILS
Chr. Hansen
10-12 Bøge Allé
Hørsholm
DK-2970
Denmark
Website
Mail
Call

+45 45 74 74 74




Printer
+45 45 74 88 88

HEALTH CATEGORIES

digestive health


Linkedin   
Twitter   
Youtube   

Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 145 years to enable sustainable agriculture, better food and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 40,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As one of the world’s most sustainable companies, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.



Articles On Nutrition Insight
Novonesis Capital Markets Day

NUTRITION & HEALTH NEWS

Novonesis unveils the latest in nutritional biosolutions at first Capital Markets Day since merger

19 Jun 2024 --- Novonesis held its first Capital Markets Day since the merger of Chr. Hansen and Novozymes. In London, UK, the full management team talked to investors, analysts and the media about... Read More

Several people look at the window of an office.

BUSINESS NEWS

Beyond The Headlines: Chr. Hansen and Novozymes merger finalized, NAD advises BA Sports Nutrition on claims

02 Feb 2024 --- This week in nutrition news, the merger of Novozyme and Chr. Hansen into the newly minted Novonesis was completed, while legacy Novozymes revealed marked growth for 2023. At the... Read More

Girl drinks glass of milk.

NUTRITION & HEALTH NEWS

Beyond infant formula: Industry predicts HMO growth in gut health and immunity

25 Jan 2024 --- Human milk oligosaccharides (HMOs) — found naturally in human breast milk — are increasingly common in infant dairy formulations looking to offer nutritional benefits... Read More

Businessmen shaking hands

BUSINESS NEWS

Chr. Hansen and Novozymes merger cleared by EU, Kerry to acquire lactase enzyme business

13 Dec 2023 --- The European Commission has cleared the merger between Danish bioscience players Novozymes and Chr. Hansen, conditional upon full compliance with the commitments offered by the... Read More

A green graphic which says Industry Review 2023 in white.

NUTRITION & HEALTH NEWS

Nutrition industry review 2023: Mega-mergers, ingredient innovations, future-proofing nutrition

12 Dec 2023 --- As we look forward to ringing in the new year, Nutrition Insight revisits some of the biggest news stories of 2023. From innovative “organ-on-a-chip” advancements to... Read More




Videos
FormattedPicture

Vitafoods Europe 2024 live: Novonesis spotlights innovative human health biosolutions

15 May 2024 --- At Vitafoods Europe in Geneva, Switzerland, we talk with Linda Neckmar, SVP of human health biosolutions at Novonesis and its VP of human health biosolutions, Jakob Rasmussen, to explore what the company is featuring at its first trade show since its merger with Chr. Hansen and glimpse what we can expect to see in the coming years. Novonesis is featuring its nutrition solutions at booth #H99, giving presentations at booth #B110 and conducting two symposiums at booth #K232 on the morning and afternoon of May 15. 

FormattedPicture

Welcome to Novonesis - Better lifelong health starts here.

01 May 2024 --- We may be a new company, but we’ve got a big head start thanks to more than a century of experience from Chr. Hansen and the Novo Group. With our comprehensive portfolio that's broad and deep enough to meet people’s complex and changing needs, we are your end-to-end partner in biosolutions for better products and healthier humans.This video is from Novonesis. 

FormattedPicture

HMOs show direct positive health effects independent of the gut microbiome

20 Jun 2023 --- Yannik Schönknecht, a scientific advisor at Chr. Hansen, takes us through the latest Human Milk Oligosaccharides (HMOs) research and reveals what is coming up in this field. Schönknecht says that HMOs are prebiotic and have been shown to bring several health benefits independent of the gut microbiome. He predicts that improved technologies and production capabilities will drive the increased interest in the gut microbiome. 

FormattedPicture

Chr. Hansen talks non-alcoholic innovation and the future of fermented beverages

14 Sep 2022 --- Nathalia Edwards, commercial development manager, fermented beverages at Chr. Hansen, examines some of the key trends emerging at Drinktec 2022. She also details the company’s solution, NEER Yeast, for making non-alcohol beer and looks at future innovations in fermented beverages.

FormattedPicture

Chr. Hansen expands into emerging gut-brain and weight management categories

12 May 2022 --- Chr. Hansen is expanding the breadth of its portfolio in addition to reinforcing its core portfolio of gut and immune health. Recent studies have revealed the company’s strains have a positive impact on sleep in night shift workers, for example. Linda Neckmar, senior vice president for human health, also flags women’s health as the fastest growing area across regions. 




Podcasts
FormattedPicture

NewsBite Podcast (Feb 28-Mar 4): “Vitamin D may be cost-effective sleep aid”

07 Mar 2022 --- This week’s NewsBite podcast details how vitamin D supplements could improve sleep quality, a Chr. Hansen study highlighting opportunities in the probiotic space and Danone’s Activia+ Multi-Benefit Drinkable Yogurt launch.

FormattedPicture

NewsBite Podcast (May 31-Jun 4): “Chr. Hansen and Lonza JV lands manufacturing licenses”

07 Jun 2021 --- This NewsBite podcast delves into Chr. Hansen and Lonza’s joint venture, Bacthera, receiving manufacturing licenses to start supplying live biotherapeutic products. Meanwhile, Probi partnered on probiotic research for vaginal health NPD targeting the “underserved” market. Also, a Safefood report revealed that online conversations about healthy diets are missing input from health experts.

FormattedPicture

NewsBite Podcast (August 24-28): “Experts call for fiber labeling distinction, a2 Milk Company grows infant nutrition sector”

31 Aug 2020 --- This latest episode of NutritionInsight’s NewsBite podcast delves into the top industry news from last week, including proposals for new ways to discuss dietary fiber and synbiotics. There have also been moves in the infant nutrition space from businesses including the a2 Milk Company and Nestlé. Read more:Fiber classification: ICQC report says labeling distinction is “strongly advised”a2 Milk Company grows infant nutrition sector with US$176m Mataura Valley Milk dealChr. Hansen targets “different path” with expansion of microbial capacities

FormattedPicture

NewsBite Podcast (June 8-12): “DSM snaps up Erber for US$1bn, Activ’Inside in US$19m collaboration to fight cognitive decline in elderly”

15 Jun 2020 --- In this week’s episode of the NewsBite podcast, NutritionInsight reports on numerous acquisitions, including those from DSM, Chr. Hansen and Nestlé Health Science. Meanwhile, research is booming in spaces including respiratory infections and the microbiome. Read more:DSM snaps up Erber for US$1bn as it prioritizes acquisitionsNestlé Health Science’s HMOs slash respiratory tract infections in infants with cow’s milk protein allergyActiv’Inside in US$19m collaboration to fight cognitive decline in elderly

FormattedPicture

NewsBite Podcast (April 13-17): “Chr. Hansen launches online probiotic education platform, Fatty acid and sweet wormwood on road to clinical trials for COVID-19”

20 Apr 2020 --- NutritionInsight’s recurring podcast returns to provide the most important industry-related news and information from the past few days. This week, research related to COVID-19 extended into eicosapentaenoic acid free fatty acid, sweet wormwood extract and probiotics, while nutrition companies continue to navigate supply chain disruptions. Read more:Moves for immunity: Chr. Hansen launches online probiotic education platformFatty acid and sweet wormwood on road to clinical trials for COVID-19AHPA reports supply chain disruptions to USDA amid mounting industry concerns




Webinars
FormattedPicture

Naturally relieve loose stools and digestive distress with probiotics

21 Nov 2023 --- Chr. Hansen delves into the areas of gut and gut-brain health: Christopher Martoni, PhD will take you on a journey through the fascinating science behind Chr. Hansen’s newest probiotic strain: CLEPIUS™ L. plantarum.

FormattedPicture

How HMOs can support the immune system – new clinical and preclinical insights

09 May 2023 --- Join this webinar to dive into the scientific field of HMOs and its latest insights. Stina Rikke Jensen, Ph.D., will focus on the signature function of HMOs and present new scientific data. Combined with the new data, Stina will provide an overview of the current evidence on HMOs and discuss how to further substantiate the promising potential of HMOs for food applications.

FormattedPicture

The benefit of probiotics in the gut and gut-brain axis

26 Jan 2023 --- Join this webinar to learn how specific scientifically proven strains like Chr. Hansen’s DDS-1® can support gastrointestinal health and alleviate stress related to gastrointestinal discomfort.Our expert team will walk you through the fascinating connection between the gut and the brain, explain probiotic modes of action, and spotlight the strong clinical evidence on Chr. Hansen’s DDS-1® strain. 

FormattedPicture

Support your immune health with probiotics

27 Oct 2022 --- Probiotics are well-known for their benefits in digestive health, but did you know that 70% of our immune system is located in the gut? There are various ways, in which probiotics can interact with and support the immune system, making it more efficient in responding to immune challenges. This means that consumers who supplement with probiotics may be less susceptible to immune challenges and may recover quicker.Join us for this webinar to learn more about how specific probiotic strains like Chr. Hansen’s L. CASEI 431® can support the body's own defense. Dr. Zonderland will take you through the remarkable connection between the gut and the immune system, explain probiotic modes of action and showcase the strong clinical evidence on Chr. Hansen's L. CASEI 431® strain. 

FormattedPicture

The intimate relationship between the microbiome and immune system – and the important role probiotics may play

19 Nov 2020 --- There is a complex relationship between the microbiome and immune system, with the right probiotics having the potential to make a major impact. This Chr. Hansen webinar explains what to look for when selecting probiotic strains, as well as examining the clinical studies linking probiotics with the immune system.




A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W